Other languages Lee's Pharmaceutical Holdings Limited

Equities

950 KYG5438W1116

Market Closed - Hong Kong S.E. Other stock markets 09:09:00 03/05/2024 BST			5-day change	1st Jan Change
1.18 ^HKD	+2.61%		+9.26%	-22.88%

04-19	Lee’s Pharmaceutical's 2023 Profit Slumps 67%	MT
03-26	Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lee’s Pharmaceutical's 2023 Profit Slumps 67%	04-19
Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024	03-26
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-26
China Grants Lee's Pharmaceutical Drug Registration for Schizophrenia-Related Agitation Treatment; Shares Rise 3%	11-29
Lee’s Pharmaceutical Sells Rights for Eyprotor to Zhaoke Ophthalmology for 60 Million Yuan	11-14
Lee's Pharmaceutical Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 October 2023	30/08/23
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Lee's Pharmaceutical Holdings Limited Announces Phase IIa Clinical Trial of A F fentanyl Aerosol for Inhalation Conducted by Zhaoke Pharmaceutical Limited	21/08/23
Lee's Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023	21/08/23
Lee's Pharmaceutical Holdings Limited Appoints Cheang Yee Wah, Eva as Independent Non-Executive Director	17/05/23
Lee's Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 15 June 2023	30/03/23
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Lee’s Pharmaceutical Holdings Warns of Plunge in 2022 Profit	21/03/23
Lee's Pharmaceutical Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	20/03/23
Extended Phase 2b Study for Lee's Pharmaceutical's Tafoxiparin Concludes; Shares Slip 3%	17/02/23
Nine Lee's Pharma Products Included in China's National Reimbursement Drug List	20/01/23
Lee's Pharmaceutical Holdings Limited Announces Inclusion of Treprostinil Injection, Teglutik and Trittico in the National Reimbursement Drug List	19/01/23
Lee's Pharmaceutical's Q3 Profit More Than Doubles	24/11/22
Lee’s Pharmaceutical Q3 Profit Jumps 150%	17/11/22
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/11/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Lee's Pharmaceutical Holdings Limited

Equities

950

KYG5438W1116

Other languages

Filters